Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polyarticular Course Juvenile Idiopathic Arthritis (JIA)”

19 trials

Showing 19 of 19 results

Large-scale testing (Phase 3)Study completedNCT01667471
What this trial is testing

A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 6
Large-scale testing (Phase 3)Study completedNCT02277444
What this trial is testing

Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy

Who this might be right for
Arthritis, Juvenile
Janssen Research & Development, LLC 130
Large-scale testing (Phase 3)Study completedNCT01673919
What this trial is testing

A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis From France Who Completed WA19977 Core Study

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 7
Large-scale testing (Phase 3)Looking for participantsNCT06654882
What this trial is testing

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

Who this might be right for
Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
Duke University 400
Large-scale testing (Phase 3)Study completedNCT02592434
What this trial is testing

Efficacy Study Of Tofacitinib In Pediatric JIA Population

Who this might be right for
Juvenile Idiopathic Arthritis
Pfizer 225
Not applicableStudy completedNCT00783510
What this trial is testing

Juvenile Idiopathic Arthritis (JIA) Registry

Who this might be right for
Juvenile Idiopathic ArthritisJIA
AbbVie 849
Not applicableEnded earlyNCT01557452
What this trial is testing

Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Italfarmaco 1
Large-scale testing (Phase 3)Study completedNCT01727986
What this trial is testing

An Extension Long-Term Study of RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular Juvenile Idiopathic Arthritis Who Completed The WA19977 Study

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 11
Testing effectiveness (Phase 2)Study completedNCT02776735
What this trial is testing

An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Sanofi 102
Large-scale testing (Phase 3)Ended earlyNCT03781375
What this trial is testing

Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Rheumatoid Arthritis
Amgen 25
Testing effectiveness (Phase 2)Study completedNCT00037648
What this trial is testing

Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Chronic Arthritis
Amgen 86
Large-scale testing (Phase 3)Study completedNCT00988221
What this trial is testing

Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 188
Large-scale testing (Phase 3)Study completedNCT01835470
What this trial is testing

Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan

Who this might be right for
Juvenile Idiopathic Arthritis
Bristol-Myers Squibb 23
Testing effectiveness (Phase 2)Ended earlyNCT01261624
What this trial is testing

Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic Arthritis

Who this might be right for
Polyarticular Course Juvenile Idiopathic Arthritis
Italfarmaco 16
Early research (Phase 1)Study completedNCT01904279
What this trial is testing

Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 52
Early research (Phase 1)Active Not RecruitingNCT03725007
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis (JIA)
AbbVie 124
Early research (Phase 1)Study completedNCT02165345
What this trial is testing

Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 82
Large-scale testing (Phase 3)Study completedNCT01550003
What this trial is testing

Pediatric Arthritis Study of Certolizumab Pegol

Who this might be right for
Polyarticular-course Juvenile Idiopathic Arthritis (JIA)
UCB BIOSCIENCES GmbH 193
Large-scale testing (Phase 3)Ended earlyNCT01575769
What this trial is testing

An Extension Study to WA19977 in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 41

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation